Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Clinical and Economic Implications of Genetic Testing for Warfarin Management

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
Agency for Healthcare Research and Quality (AHRQ)
Information provided by (Responsible Party):
University of Chicago
ClinicalTrials.gov Identifier:
NCT00964353
First received: August 12, 2009
Last updated: May 17, 2016
Last verified: May 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: December 2016
  Primary Completion Date: August 2012 (Final data collection date for primary outcome measure)